Also trades as: CING (NASDAQ) · $vol 2M
CINGW NASDAQ
Cingulate Inc.
1W: -24.2%
1M: -44.0%
3M: -81.0%
YTD: -91.5%
1Y: -89.8%
3Y: -97.7%
$0.01
+0.00 (+0.00%)
Weekly Expected Move ±54.3%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
16 relationships16
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2022-08-11
Earliest Filing
2026-03-24
Latest Filing
partner: 6
investor: 4
target: 2
acquirer: 2
customer: 2
Counterparties (Filed by CINGW)
16 relationshipsCompanies named in CINGW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| A.G.P./Alliance Global Partners | — | partner | Sales Agent for the issuance and sale of Common Stock | 2026-03-24 | View |
| CINGULATE INC. | CINGW | target | Company selling common stock to investor | 2025-07-22 | View |
| LINCOLN PARK CAPITAL FUND, LLC | — | investor | Investor purchasing up to $25,000,000 of common stock | 2025-07-22 | View |
| Cingulate Therapeutics, LLC | CINGW | partner | Received $3,000,000 grant for clinical and manufacturing development of CTx-2103 | 2025-04-09 | View |
| Cingulate Inc. | CINGW | acquirer | Company issuing and selling a Promissory Note | 2024-12-23 | View |
| Streeterville Capital, LLC | — | investor | Investor purchasing the Promissory Note | 2024-12-23 | View |
| Cingulate Therapeutics LLC | CINGW | partner | Subsidiary providing a joint and several guaranty | 2024-12-23 | View |
| Cingulate Works, Inc. | CINGW | partner | Subsidiary providing a joint and several guaranty | 2024-12-23 | View |
| Cingulate Therapeutics LLC | CINGW | target | Company issuing warrants to convert promissory note | 2024-01-29 | View |
| Cingulate Inc. | CINGW | acquirer | Parent company issuing pre-funded warrants | 2024-01-29 | View |
| Werth Family Investment Associates LLC | — | investor | Holder converting promissory note into warrants | 2024-01-29 | View |
| Cingulate Inc. | CINGW | partner | Parent company issuing pre-funded warrants upon conversion of the debt. | 2023-09-11 | View |
| Werth Family Investment Associates LLC | — | investor | Holder of the original promissory note converting it into warrants. | 2023-09-11 | View |
| Cingulate Therapeutics LLC | CINGW | customer | Borrower of $8,000,000 under an amended promissory note | 2023-05-10 | View |
| H.C. Wainwright & Co., LLC | — | partner | Sales agent for At The Market Offering Agreement | 2023-01-03 | View |
| Cingulate Therapeutics LLC | CINGW | customer | Borrower of $5,000,000 promissory note | 2022-08-11 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-02 | Officer/Director Change; Exhibits | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-07-23 | Officer/Director Change | View | |
| 2026-07-14 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-07-02 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-06-16 | Regulation FD; Exhibits | View | |
| 2026-06-02 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-19 | Officer/Director Change | View | |
| 2026-05-14 | Earnings Release; Exhibits | View | |
| 2026-04-02 | Officer/Director Change | View | |
| 2026-03-24 | Material Agreement; Shareholder Vote | Agreement | View |
| 2026-02-17 | Unregistered Sales of Equity Securities; Departure/Election of Directors; Appointment of Officers; R | View | |
| 2026-02-06 | Unregistered Sales of Equity Securities; Other Events | View | |
| 2026-01-28 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Art | Agreement | View |
| 2026-01-15 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-02 | Unregistered Sales of Equity Securities | View | |
| 2025-12-15 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-10 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Regulation FD Dis | Agreement | View |
| 2025-10-14 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR